Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 50 of Moleculin Biotech, Inc.'s SEC filings and found 24 warrant series, 1 ATM program, 1 equity line, 5 shelf registrations, 6 S-1 registrations and 3 completed offerings on file for MBRX. The latest dilution event on file is ATM sales on Sep 23, 2026. Analysis updated Nov 2, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
CMMBChemomab Therapeutics Ltd. American Depositary Share
LEXXLexaria Bioscience Corp.
TOVXTheriva Biologics, Inc.
TPSTTempest Therapeutics, Inc.
LTRNLantern Pharma Inc.
SNGXSoligenix, Inc.
MTVAMetaVia Inc.
CURXCuranex Pharmaceuticals Inc Common Stock
BCLIBrainstorm Cell Therapeutics Inc.
BLRXBioLineRX Ltd
PTNPalatin Technologies, Inc.
XTLBXTL Biopharmaceuticals Ltd. American Depositary Shares
VTGNVistaGen Therapeutics, Inc.
INABIN8bio, Inc.
KPRXKiora Pharmaceuticals, Inc.